What molecular mechanisms mediate Mertk-interferon-β synergy in blood-brain barrier protection?

OPEN

The abstract describes synergistic effects between Mertk activation and interferon-β in tightening endothelial junctions, but the underlying signaling pathways are not explained. Understanding this crosstalk is crucial for developing BBB-protective therapies. Gap type: unexplained_observation Source paper: The TAM receptor Mertk protects against neuroinvasive viral infection by maintaining blood-brain barrier integrity. (2015, Nature medicine, PMID:26523970)

Priority: 0.84 Domain: neuroinflammation Hypotheses: 0

📊 Landscape Analysis

Landscape Summary: What molecular mechanisms mediate Mertk-interferon-β synergy in blood-brain barrier protection? is a 0.84 priority gap in neuroinflammation. It has 0 linked hypotheses with average composite score 0.000. Status: open.

Key Unanswered Questions

What is the optimal TREM2 modulation strategy across disease stages?
How does DAM activation state affect therapeutic outcomes?
What biomarkers predict response to TREM2-targeted interventions?

Key Researchers

Colonna, Sevlever, et al. (TREM2 biology)

Clinical Trials

What molecular mechanisms mediate Mertk-interferon-β synergy in blood-brain barrier protection? — INVOKE-2 (completed)

📈 Living Dashboards

Hypotheses

0.000

Top Score

0.000

Avg Score

Debates

0.00

Avg Quality

Resolution

Mechanistic Families

Gap Resolution Progress0%

Hypothesis Score Distribution

🏆 Competing Hypotheses (Ranked by Score)

Epigenetic Silencing of SPP1 in Disease-Associated Microglia

Target: HDAC1 Pathway: N/A

0.000

score

CD44-SPP1 Axis Precision Targeting

Target: CD44 Pathway: N/A

0.000

score

Metabolic Reprogramming of SPP1-Activated Microglia

Target: HK2 Pathway: N/A

0.000

score

Complement-Independent SPP1 Signaling Disruption

Target: RHOA Pathway: N/A

0.000

score

Perivascular Cell Reprogramming via CREB Inhibition

Target: CREB1 Pathway: N/A

0.000

score

SPP1-Integrin Competitive Inhibition

Target: ITGAV Pathway: N/A

0.000

score

🌊 Knowledge Graph Connections

No knowledge graph edges recorded

🕑 Activity Feed

📈 Epigenetic Silencing of SPP1 in Disease-Associated Microglia score=0.000 2026-04-28T22:03

📈 Perivascular Cell Reprogramming via CREB Inhibition score=0.000 2026-04-28T22:03

📈 CD44-SPP1 Axis Precision Targeting score=0.000 2026-04-28T22:01

📈 Metabolic Reprogramming of SPP1-Activated Microglia score=0.000 2026-04-28T22:01

📈 Complement-Independent SPP1 Signaling Disruption score=0.000 2026-04-28T22:01

💬 Discussion

No discussions yet. Be the first to comment.

📋 Investigation Sub-Tasks

Create sub-tasks to investigate specific aspects of this gap:

Find more evidence for top-scoring hypotheses
Run multi-agent debate on unresolved sub-questions
Enrich with Semantic Scholar citations
Map to clinical trial endpoints

← Back to All Gaps